NASDAQ$BNTX
BioNTech SE-ADR · Q2 2019 earnings
Q2 2019 earnings · · Investor relations
Headline financials
Revenue & EPS history
BioNTech SE · Revenue · Quarterly
€25.8M
Q2 2019
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports
-0.4%
Avg return
Earnings day
+0.2%
Avg return
5 days after
+5.7%
Avg return
30 days after
39%
9 / 23 earnings
Positive
+13.8%
Q4 2020
Best reaction
-14.6%
Q4 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2025 | -3.7% | -5.3% | -9.9% | |
| Q2 2025 | +2.5% | +4.0% | -6.4% | |
| Q4 2024 | -3.2% | -8.6% | -13.5% | |
| Q3 2024 | -0.5% | -0.8% | +2.9% | |
| Q1 2024 | -2.0% | -1.1% | +10.5% | |
| Q4 2023 | -2.3% | -1.2% | -7.8% | |
| Q3 2023 | +6.9% | +3.9% | +5.8% | |
| Q2 2023 | -4.4% | +0.4% | +12.8% | |
| Q1 2023 | -3.5% | -2.9% | +0.9% | |
| Q4 2022 | -4.1% | -2.8% | -13.7% | |
| Q3 2022 | +4.3% | +0.1% | +5.4% | |
| Q2 2022 | -14.1% | -12.4% | -21.3% | |
| Q4 2021 | -1.1% | +16.6% | +18.8% | |
| Q1 2022 | +6.1% | +16.6% | +18.8% | |
| Q3 2021 | -3.0% | -1.8% | +17.2% | |
| Q2 2021 | +7.1% | -3.0% | -13.6% | |
| Q1 2021 | +7.8% | +4.9% | +31.5% | |
| Q4 2020 | +13.8% | +10.8% | +38.9% | |
| Q3 2020 | +4.4% | +1.1% | +23.6% | |
| Q2 2020 | -6.5% | -7.2% | -17.2% | |
| Q1 2020 | -3.0% | -1.0% | -2.8% | |
| Q4 2019 | -14.6% | -14.9% | -23.4% | |
| Q3 2019 | +3.7% | +9.6% | +74.9% | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro